Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NEUROSKIN Mild
- Development stage
- Unknown
- Lead developer
- avVaa World Health Care Products
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
NEUROSKIN Mild is a natural, mineral-based topical skin care product developed by avVaa World Health Care Products. It is part of the NEUROSKIN product line, which utilizes patented European formulas to address various dermatological conditions including acne, psoriasis, eczema, and pruritus (itching). The product is positioned as an over-the-counter (OTC) therapeutic treatment and has been evaluated in clinical trials in Germany, specifically in comparison to the more potent NEUROSKIN Forte. It is designed for distribution through mass-market retail channels and is formulated to be FDA-compliant for global and United States markets.
- Brand names
- NEUROSKIN Mild
Beyond the preview
Go deeper on NEUROSKIN Mild.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NEUROSKIN Mild.